Report: European drugmakers say they are ‘losing ground’ to US and Chinese rivals

The Guardian — World has reported on “Report: European drugmakers say they are ‘losing ground’ to US and Chinese rivals,” presenting it as the central development in the source material available for this brief.

Some of continent’s largest pharma firms write to national leaders calling for action to safeguard their futures Some of Europe’s largest pharmaceutical companies have stated the continent is “losing ground” to rivals including the US and China in developing new drugs and attracting investment. The report also notes that The chairs of nine companies, including Britain’s AstraZeneca, GSK and Denmark’s Novo Nordisk, wrote to Andy Burnham and the national leaders of other European countries on Tuesday to call for action to “safeguard our companies’ future”.

Any statements, estimates or characterisations remain attributed to the people or organisations identified by the source. The excerpt alone does not provide a complete documentary record or necessarily include responses from every party involved.

Official statements or subsequent reporting may add context as the story develops. For now, this account is confined to information directly supported by the provided headline and excerpt.